New Wave Of Clinical Trials May Throw Indian Regulators Off Balance - DIA Conference
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India's ability to handle a growing number of clinical trial applications has reached a tipping point as ethics committees, regulators and other stakeholders struggle to meet demand which is expected to double in 2008, industry officials said
You may also be interested in...
PharmAsia News Notable Notes: Kotak Initiates Coverage Of Five Indian CMO, CRO Firms
NEW DELHI - Efforts by five smaller Indian drug companies to attract contract research and manufacturing stand to benefit from multinational firms cost-cutting efforts in sourcing active pharmaceutical ingredients and increased clinical trials in the country
PharmAsia News Notable Notes: Kotak Initiates Coverage Of Five Indian CMO, CRO Firms
NEW DELHI - Efforts by five smaller Indian drug companies to attract contract research and manufacturing stand to benefit from multinational firms cost-cutting efforts in sourcing active pharmaceutical ingredients and increased clinical trials in the country
Negative Perceptions of Clinical Trials In India Persist – Clinical Trials Panel
SAN FRANCISCO - Companies looking to initiate clinical trials in India must tread lightly when navigating ethics committees, according to panelists at a recent conference on various aspects of entering clinical trials in Asia